Eugene M Johnston sold $5,975 of MGRX
CFO at MANGOCEUTICALS, INC.. 5,000 shares at an average of $1.20, traded Dec 9, 2025, filed Dec 11, 2025.
Score components
- +22RoleCFO
- 0Trade size$6k at market
- 0Share of holdings soldSold 3.9% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -31.0%, 3m -65.2%, 6m -67.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-027238, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 9, 2025 | SOpen-market sale Common Stock | -5,000 | $1.20 | $5,975 | 123,333 | Dec 11, 2025 |
Related signals
Other insiders at MANGOCEUTICALS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | MGRXsell MANGOCEUTICALS, INC. | Eugene M Johnston CFO | $3,884 3,333 shares | -3% | |
| 22Weak | MGRXsell MANGOCEUTICALS, INC. | Eugene M Johnston CFO | $11k 10,000 shares | -7% | |
| 46Moderate | MGRXsell MANGOCEUTICALS, INC. | Alex P. Hamilton director | $153k 125,000 shares | -97% | |
| 41Moderate | MGRXsell MANGOCEUTICALS, INC. | Alex P. Hamilton director | $40k 125,000 shares | -71% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.